Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 2001 3(3):174-183; DOI:10.1215/15228517-3-3-174
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sands, S. A.
Right arrow Articles by Finlay, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Duke University Press

Clinical Therapy Trials—Quality of Life

Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: From the First International CNS Germ-Cell Tumor Study

Stephen A. Sands1, Stewart J. Kellie, Amy L. Davidow, Blanca Diez, Judith Villablanca, Howard L. Weiner, Maria C. Pietanza, Casilda Balmaceda and Jonathan L. Finlay

Departments of Psychiatry (S.A.S.) and Pediatrics (S.A.S., H.L.W., J.L.F.), New York University School of Medicine, New York, NY 10016; The Children's Hospital at Westmead and the University of Sydney, Sydney, Australia 2156 (S.J.K.); Department of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School, Newark, NJ 07103 (A.L.D.); Gutierrez Children's Hospital, Buenos Aries, Argentina 1425 (B.D.); Children's Hospital of Los Angeles, Los Angeles, CA 90027 (J.V.); State University of New York, Brooklyn, NY 11203 (C.B.); and Neurological Institute, Columbia-Presbyterian Medical Center, New York, NY 10032 (M.C.P.)

1 Address correspondence and reprint requests to Stephen A. Sands, New York University, Hassenfeld Cancer Center, 317 E. 34th St., New York, NY 10016.

Abstract

This study evaluated the quality of life and neuropsychologic functioning among patients enrolled between 1989 and 1993 in the First International CNS Germ-Cell Tumor Study. Quality-of-life questionnaires (Short Form-36 or Child Health Questionnaire) were completed on 43 patients at median follow-up of 6.1 years after diagnosis (range, 4.5-8.8 years), and intellectual and academic testing was performed on 22 patients. Psychosocial and physical functioning of patients aged 19 years and older at follow-up was within the average range, whereas the same functioning for patients aged 18 years and younger, as reported by their parents at follow-up, was low average and borderline, respectively. Overall psychosocial and physical health summary scores were positively correlated with age at diagnosis for both groups combined. Those who received CNS radiation therapy (n = 29) reported significantly worse physical health, but similar psychosocial health, compared with those treated without radiation. Neuropsychologic testing indicated full-scale and verbal IQ, reading, spelling, and math skills in the average range, and performance IQ in the low average range. Intelligence and math skills were positively correlated with age at diagnosis. Those with germinomas significantly outperformed those with nongerminomatous/mixed tumors on all neuropsychological measures administered. Younger patients diagnosed with CNS germ-cell tumors are at increased risk for psychosocial and physical problems as well as neuropsychologic deficits. Exposure to irradiation adversely affects overall physical functioning, whereas tumor pathology appears to be a salient neurocognitive risk factor. Collaborative and randomized studies are required to further elucidate the late effects arising from factors such as age at diagnosis, tumor histology, level of irradiation therapy, and chemotherapy toxicity among these young and potentially curable patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Neuro Oncol DukeHome page
A. T. Reddy, J. C. Wellons III, J. C. Allen, J. B. Fiveash, H. Abdullatif, K. W. Braune, and P. A. Grabb
Refining the staging evaluation of pineal region germinoma using neuroendoscopy and the presence of preoperative diabetes insipidus
Neuro-oncol, April 1, 2004; 6(2): 127 - 133.
[Abstract] [PDF]


Home page
JCOHome page
S. J Kellie, H. Boyce, I. J Dunkel, B. Diez, M. Rosenblum, L. Brualdi, and J. L Finlay
Primary Chemotherapy for Intracranial Nongerminomatous Germ Cell Tumors: Results of the Second International CNS Germ Cell Study Group Protocol
J. Clin. Oncol., March 1, 2004; 22(5): 846 - 853.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
T. Fietz, E. Thiel, C. Baldus, I. W. Blau, G. Stoltenburg, and W. U. Knauf
Successful treatment of extracranially metastasized pineal gland germinoma with high-dose methotrexate
Ann. Onc., October 1, 2002; 13(10): 1681 - 1685.
[Abstract] [Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2001 by Society for Neuro-Oncology